The revenue stands at ₹4,921.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 17.25 per cent from ₹4,197.00 crore. This corresponds to a year-on-year *(YoY) growth of 54.85 per cent.
Operating Profit stands at ₹1,643.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 27.36 per cent from ₹1,290.00 crore. This corresponds to a year-on-year *(YoY) growth of 59.21 per cent.
PBDT stands at ₹1,326.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 27.87 per cent from ₹1,037.00 crore. This corresponds to a year-on-year *(YoY) growth of 41.21 per cent.
Profit Before Tax stands at ₹733.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 38.56 per cent from ₹529.00 crore. This corresponds to a year-on-year *(YoY) decline of 0.68 per cent.
Net Profit stands at ₹566.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 55.49 per cent from ₹364.00 crore. This represents a 3.28 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Torrent Pharma. | -0.36% | 2.04% | -0.80% | 11.39% | 15.85% | 35.55% |
| Sun Pharma.Inds. | 0.16% | 0.98% | -2.16% | 3.02% | 9.74% | 15.71% |
| Divi's Lab. | 0.73% | 1.08% | 16.25% | 24.72% | 36.42% | 39.61% |
| Cipla | 1.53% | 0.53% | 1.59% | 2.77% | 8.41% | -9.71% |
| Zydus Lifesci. | 0.34% | -2.05% | -1.85% | 6.72% | 22.13% | 12.14% |
| Lupin | -0.76% | -2.48% | -8.43% | -3.35% | -1.87% | 11.52% |
Chairman/ED & CEO : Samir Mehta
ED / MD / Promoter : Aman Mehta
Non-Exec & Non-Independent Dir : Jindal Mehta
Lead Independent Non Executive Director : Manish Choksi
Independent Non Exe. Director : Nayantara Bali
Independent Non Exe. Director : Nikhil Khattau
Company Sec. & Compli. Officer : Chintan M. Trivedi
Chairman Emeritus : Sudhir Mehta